RPC1063

ozanimod · Celgene

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for RPC1063, covering 2017-01-27 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis [Phase 3]